AUTL
Autolus Therapeutics
AUTL
AUTL
67 hedge funds and large institutions have $144M invested in Autolus Therapeutics in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
37% less capital invested
Capital invested by funds: $229M → $144M (-$84.8M)
Holders
67
Holding in Top 10
1
Calls
$95K
Puts
–
Top Buyers
| 1 | +$2.25M | |
| 2 | +$1.65M | |
| 3 | +$1.03M | |
| 4 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$548K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$422K |
Top Sellers
| 1 | -$3.85M | |
| 2 | -$3.57M | |
| 3 | -$1.59M | |
| 4 |
EP
Eversept Partners
New York
|
-$1.55M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$1.23M |